Metabolic secondary outcomes included HbA1c, blood pressure (systolic and diastolic), HR, total cholesterol, triglycerides, hsCRP, HbA1c in participants with pre-existing pre-diabetes and T2D, blood pressure in participants with pre-existing hypertension and changes in T2D, and hypertension medication used in participants with T2D and hypertension, respectively
Is the peptide stored correctly and within shelf life
Beyond the gut, FMT provides many improvements in the brain, including reversing cognitive decline, neuroprotective mechanisms by reducing alpha-synuclein accumulation, and restoring striatal levels of dopamine and serotonin (Hashish and Salama, 2023)
Brain glutathione levelsa novel biomarker for mild cognitive impairment and Alzheimers disease